Nighttime Snacking Market Soars Past $50 Billion, with Nightfood Set to Take Center Stage
New York, New York--(Newsfile Corp. - June 15, 2021) - PCG Digital -- Nightfood Holdings (OTCQB: NGTF), a better-for-you snack company, is targeting the $50 billion Americans spend each year on nighttime snacks. Leading with its award-winning, sleep-friendly ice cream, the company is dedicated to creating nutritional and functional options for the 80% of Americans who snack regularly at night. As the company develops its portfolio of snack products, Nightfood's recent results showcase a clean...
2021-06-15 8:30 AM EDT
Shining a Light on Soligenix's HyBryte(TM) Growth Opportunity
New York, New York--(Newsfile Corp. - June 3, 2021) - PCG Digital -- When Soligenix (NASDAQ: SNGX) updated its NDA rollout plan, the market quickly reacted. While the timeline was adjusted, the big picture and ultimate end game remain the same. With conditional acceptance of the HyBryteTM name by the FDA and positive news in Japan and the UK, Soligenix continues to move forward in its aim to treat cutaneous T cell lymphoma.Soligenix is developing SGX301 (recently branded HyBryteTM) for...
2021-06-03 8:30 AM EDT
Bubblr Is Making All the Right Moves on the Road to Uplisting
New York, New York--(Newsfile Corp. - May 27, 2021) - PCG Digital -- The journey from the OTC market to Nasdaq or NYSE can be a long and winding road, but some companies make the journey worthwhile with key milestones and notable progress along the way. Bubblr (BBLR), an ethical technology company committed to changing the internet for the better, is one of those companies.On April 13, 2021, the U.S. Patent and Trademark Office approved a Bubblr patent application titled...
2021-05-27 8:30 AM EDT
Lexaria DehydraTECH(TM) 2.0 Outperforms MCT in 2021 R&D Study
New York, New York--(Newsfile Corp. - May 25, 2021) - PCG Digital -- The positive results keep rolling in for Lexaria (LEXX). They recently released R&D study results for three new DehydraTECHTM 2.0 formulation variations that significantly outperformed traditional MCT oil-based formulations that have become CBD industry standard.Though new to NASDAQ, Lexaria Bioscience Corp. has been producing positive test results with their patented DehydraTECHTM bio-absorption technology since 2016. The...
2021-05-25 8:30 AM EDT
AIkido Pharma Has Pending Data Results on June 4th, with Strongest Balance Sheet in Its History While Trading Below Cash
New York, New York--(Newsfile Corp. - May 20, 2021) - PCG Digital -- Anthony Hayes is an optimist, with good reason. The CEO of AIkido Pharmaceuticals (NASDAQ: AIKI), according to the company's Q1 report and a press release recently issued, is expecting positive results from human clinical trials of dual-action peptide receptor radionuclide therapy (PRRT) with notable insider buying in the open market displaying his strong belief in the Company's prospects.Developed by Weill Cornell Medicine...
2021-05-20 3:24 PM EDT
LiveXLive Media Raises Guidance and Its Investor Presentations at Needham's and J.P. Morgan's Tech & Media Conferences
New York, New York--(Newsfile Corp. - May 20, 2021) - PCG Digital -- With LiveXLive (NASDAQ: LIVX) presenting at premier investor conferences on May 19th and the 26th that will be attended by some of the biggest institutional investors, it will be very interesting to hear more about what is driving the company's growth. Last month, LIVX announced it was increasing its revenue guidance for the fiscal year ending March 31, 2022, to $100 million to $110 million with Adjusted...
2021-05-20 8:30 AM EDT
AIKI Featured as Stock to Watch Ahead of Significant Key Milestones
New York, New York--(Newsfile Corp. - May 19, 2021) - PCG Digital -- Continuing the barrage of good-news announcements that began with its first quarter results and strong balance sheet reports, Alkido Pharma Inc. (NASDAQ: AIKI) was recently highlighted in two key investor features. A biotechnology company based in New York, Alkido Pharma is working to develop a diverse portfolio of early and mid-stage small-molecule anti-cancer therapeutics. The newsworthy company also partners with leading...
2021-05-19 8:30 AM EDT
AIKI's Near Term Catalyst Approaching this Quarter with Strong Cash Balance Sheet for Strategic Initiatives
New York, New York--(Newsfile Corp. - May 13, 2021) - PCG Digital -- Things seem to be heating up for (NASDAQ: AIKI) with a near term potential catalyst quickly approaching this quarter and several others planned throughout the remainder of the year. Management has been filing form 4s showing open market buying which typically signals strong faith in the company and signifies how undervalued they believe the stock may be at these levels. Speaking of which, the stock appears to...
2021-05-13 8:30 AM EDT
When YouTubers Fight TikTokers, LiveXLive Wins
TakeawaysSocial Gloves: Battle of the Platforms will be a groundbreaking, pay-per-view boxing spectacle pitting the world's biggest social media stars from YouTube against the icons of TikTok, plus live music from some of today's hottest music stars.Produced and distributed by livestreaming platform LiveXLive, the spectacle will be held in person on June 12, 2021, socially distanced at the 30,000-seat Hard Rock Stadium, Miami Gardens, Fla. Seven undercard bouts will lead up to a headline...
2021-05-05 8:30 AM EDT
Award-Winning E-Learning Platform Projects Rapid Growth in New Markets with "Mommy Influencer" Sales System
New York, New York--(Newsfile Corp. - April 29, 2021) - PCG Digital -- Recently recognized as the "Most Outstanding Online E-Learning Platform" for 2021 in Canada, Quality Online Education Group ("QOEG"), a wholly owned subsidiary of ADGS Advisory (OTC Pink: ADGS), projects rapid growth as it expands into additional markets.What's the secret to their success? In addition to cutting edge AI technology and data research, QOEG is increasing brand awareness by using a proven successful sales...
2021-04-29 8:30 AM EDT
Lexaria Bioscience: Turning the Tide on Hypertension
New York, New York--(Newsfile Corp. - April 15, 2021) - PCG Digital -- Hypertension, or high blood pressure, is known as the "silent killer" because it causes more than 7 million deaths each year-often with next to no symptoms. Hypertension puts people at greater risk for heart disease and stroke, the leading causes of death in the United States, according to the Centers for Disease Control. Nearly half of adults in the United States have high blood pressure or are...
2021-04-15 8:30 AM EDT
Lexaria Is Expanding CBD Use Beyond Medical Applications into $2.65 Billion Marketplace
New York, New York--(Newsfile Corp. - April 8, 2021) - PCG Digital -- The team at Lexaria Bioscience (NASDAQ: LEXX), a leader in cannabinoid research, has been thinking outside the box. Utilizing DehydraTECHTM, their proprietary drug delivery technology, they are showing that its benefits can enrich more than just CBD medical applications.Though they are currently executing groundbreaking work in anti-hypertension solutions, Lexaria received their first patent in 2016 for CBD-infused...
2021-04-08 8:30 AM EDT
UPDATE: LiveXLive Leverages Diverse Channel Strategy to Accelerate Marked Growth
New York, New York--(Newsfile Corp. - April 5, 2021) - PCG Digital -- With over one million subscribers entering 2021, LiveXLive (NASDAQ: LIVX) is employing a multi-channel approach to accelerate their growth. The goal is to reach the 10 million mark by 2030, when the total available market (TAM) for music subscribers is estimated to be $1.2 billion.On February 11th, LIVX released a report that showed record growth for an eleventh consecutive quarter. Revenue for the quarter increased 96.9%...
2021-04-05 9:53 AM EDT
LiveXLive Leverages Diverse Channel Strategy to Accelerate Marked Growth
New York, New York--(Newsfile Corp. - March 31, 2021) - PCG Digital -- With over one million subscribers entering 2021, LiveXLive (NASDAQ: LIVX) is employing a multi-channel approach to accelerate their growth. The goal is to reach the ten million mark by 2030, when the total available market (TAM) for music subscribers is estimated to be $1.2 billion. On February 11th, LIVX released a report that showed record growth for an eleventh consecutive quarter. Revenue for the quarter increased...
2021-03-31 8:30 AM EDT
Why Hidden Value Stock Bubblr Is on a Mission to Fix the Internet
New York, New York--(Newsfile Corp. - March 16, 2021) - PCG Digital -- The internet is broken. With virtually no editorial oversight and search page placement awarded to the highest bidder, users are being fed news and information that is controlled by a select few. The bulk of it is filtered, politically slanted, and often inaccurate. Bubblr (BBLR)To view an enhanced version of this graphic, please visi
2021-03-16 8:30 AM EDT
Soligenix Anticipated to Achieve Multiple Milestones in 2021
New York, New York--(Newsfile Corp. - March 16, 2021) - PCG Digital -- The future is looking bright at Soligenix, Inc. In a corporate update released on February 24th, Dr. Christopher Schaber, Chairman, President and CEO, updated investors on the status of ongoing research projects. The report suggests that multiple milestones will be achieved this year and next.One of the key corporate highlights is the completion of a Phase 3 FLASH ("Fluorescent Light Activated Synthetic Hypericin") study...
2021-03-16 8:30 AM EDT
Could DehydraTECH(TM) CBD be Worth $3 Billion a Year to Lexaria?
New York, New York--(Newsfile Corp. - March 9, 2021) - PCG Digital -- Hypertension, or high blood pressure as it's commonly known, affects over three million Americans every year and is a primary or contributing cause of death for 25% of them. On a global scale, hypertension kills roughly 7.6 million people per year. Lexaria Bioscience, a Canadian biotech firm specializing in cannabinoid research, is hoping to change those numbers. DehydraTECH CBD, the company's revolutionary oral deliverable...
2021-03-09 8:30 AM EST
Soligenix is Ready for Commercialization of SGX301 (HyBryte(TM)); FDA Has Approval Process on Fast Track
New York, New York--(Newsfile Corp. - February 23, 2021) - PCG Digital -- Operational efficiency and sound financial management lead to positive results. That statement sums up why Soligenix (NASDAQ: SNGX) is fast approaching a new drug application (NDA) submission and potential FDA approval for SGX301 (synthetic hypericin), a photodynamic treatment option to battle the debilitating effects of cutaneous T-Cell lymphoma (CTCL).The most recent treatment option in their rare disease pipeline,...
2021-02-23 8:30 AM EST
As Investors Pile into Responsible Funds, Ethical Tech Company Bubblr Positions for Positive Impact on the Online Economy
New York, New York--(Newsfile Corp. - February 23, 2021) - PCG Digital -- Steven Saunders proclaims the internet is broken. Not because he can't login to his Wi-Fi, but because he sees deep-rooted injustice, something he has fought his entire career. As CEO of ethical tech company Bubblr, Inc., Saunders is at the helm of a newly public innovative powerhouse with a mission to change the system. Why? Because Bubblr believes the current model is broken: It is an...
2021-02-23 8:30 AM EST
Lexaria Outlook is Promising After Jazz Acquisition of GW
New York, New York--(Newsfile Corp. - February 9, 2021) - PCG Digital - Chris Bunka is a happy man. As CEO of Lexaria Bioscience (NASDAQ: LEXX) since 2006, he's battled to legitimize cannabinoids as a mainstream medical solution. This week, his dream is coming true. Jazz Pharmaceuticals, a major player with $2.3 billion in annual revenue, has entered the fray.The deal went down on Wednesday, February 3rd. Jazz completed an acquisition of GW Pharmaceuticals, developers of Epidiolex, the first...
2021-02-09 8:30 AM EST